News Feed

Syndicated news from King's College London School of Biomedical Sciences

Scientists have published ground-breaking scans of newborn babies' brains which researchers from all over the world can download and use to study how the human brain develops.

A new study published today in PLOS Medicine's Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.

King's Health Partners, has been awarded Cancer Research UK Centre status following a national competition. This prestigious award is recognition for the excellence of the cancer research across the partnership.

Exposure of babies to high levels of the 'fullness' hormone, leptin, in the womb irreversibly activates receptors in the brain that regulate blood pressure, according to a new study by researchers from the Division of Women's Health, part-funded by the British Heart Foundation.

Professor Adrian Hayday from the Division of Immunology, Infection & Inflammatory Disease in the Faculty, has been elected to the fellowship of the Royal Society, the UK's national academy of science. 50 Fellows are elected each year in recognition of their exceptional contributions to science, engineering and medicine.

Universities, funders and publishers of research do not adequately value the contributions of individuals who participate in "team science", particularly those at the early stages of their research careers, according to a new report from the Academy of Medical Sciences, chaired by Professor Anne Ridley from the Randall Division of Cell & Molecular Biophysics.

King's Sierra Leone Partnership (KSLP) has won a prestigious Times Higher Education Award in recognition of its work to support the development of sustainable health services in West Africa.

Researchers from the Department of Twin Research have found that muscle fitness as measured by power in the legs is strongly associated with an improved rate of ageing in the brain.

Cancer at King's Health Partners has received a prestigious European accreditation in recognition of excellence in patient care, research and training.

Scientists at King's College London have identified a single blood protein that may indicate the development of Mild Cognitive Impairment (MCI) years before symptoms appear, a disorder that has been associated with an increased risk of Alzheimer's disease or other dementias.

Premature birth can alter the connectivity between key areas of the brain, according to a new study led by King's College London. The findings should help researchers to better understand why premature birth is linked to a greater risk of neurodevelopmental problems, including autistic spectrum disorders and attention deficit disorders.

Captured by scientists at King's, images of a brain astrocyte cell and bundles of nerve fibres inside a human brain have been selected as two of the Wellcome Image Awards 2015 winning images.

The cooling of newborn babies suffering from perinatal asphyxia – a lack of oxygen at the time of birth – significantly increases their chance of survival without brain damage to later childhood (age 6-7 years), according to a Medical Research Council (MRC) funded clinical trial.

Professor Bob Hider, Emeritus Professor of Medicinal Chemistry at King's College London, has been presented with a prestigious award in recognition of his outstanding contributions to drug research.

King's College London has been awarded the Biotechnology and Biological Sciences Research Council's (BBSRC) 'Activating Impact' prize in recognition of the College's contribution to delivering real-world impact from bioscience research.

Older adults with dementia and depression living in rural China have a significantly higher risk of mortality than their urban counterparts, according to a new report by UK and Chinese scientists.

MRC PhD student Clare Finlay from the Wolfson Centre for Age-Related Diseases was the runner-up in this year's Max Perutz Science Writing Award. She received the £1,000 prize for her article explaining her research looking at ways to stop dopamine-producing brain cells from dying in Parkinson's disease.

Professor of Stroke Medicine and National Clinical Director for Stroke, Tony Rudd has been awarded a CBE in the Queen's Birthday Honours in recognition of his services to Stroke Medicine.

Researchers from King's College London have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth.

Four academics from the School of Medicine are among 44 new Fellows elected by The Academy of Medical Sciences, in recognition of excellence in medical research, innovative application of scientific knowledge and service to health care.

A study by researchers at King's College London highlights a link between lifelong exercise and improved brain function in later life.

CoCo Therapeutics Ltd created to progress retinoic acid receptor alpha agonist for Alzheimer's Disease.

Newborn imaging facility will enable scientists to understand brain development and test new treatments for brain damage.

King's College London has been awarded a six year €15m 'Synergy grant' by the European Research Council (ERC) to map the development of nerve connections in the brain before and just after birth.

Researchers at King's College London have for the first time identified a defective gene at the root of Vici syndrome, a rare inherited disorder which affects infants from birth, leading to impaired development of the brain, eyes and skin, and progressive failure of the heart, skeletal muscles and the immune system.

Researchers at King's College London have identified several cardiovascular risk factors, including smoking and high blood pressure, which may be associated with the accelerated decline of memory, learning, attention and reasoning in older adults.

Medications used to treat hypertension, diabetes and skin conditions could be doubling as treatments for Alzheimer's within 10 years according to researchers. A groundbreaking new study funded by Alzheimer's Society and led by King's College London identifies four existing drugs and one drug class which could reduce risk or slow down symptoms of the disease.

Improved home care resources for people with conditions such as dementia, who would prefer to die at home, are key to providing better end of life care and reducing the strain of the UK's ageing population on the NHS, according to researchers at King's College London.